SCHEMBL25534906

SCHEMBL25534906

c1ccc(-c2cc(-c3ccc4c(c3)sc3ccccc34)nc(-c3ccc(-c4ccc5c(c4)C(c4ccccc4)(c4ccccc4)c4ccccc4-5)c4ccccc34)n2)cc1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 3/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
F9 P00740 1/20 0.31
ALOX5 P09917 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
NTSR1 P30989 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GLA P06280 1/20 0.30
PDK2 Q15119 2/20 0.30
AURKA O14965 1/20 0.30
PDPK1 O15530 1/20 0.30
TGFBR1 P36897 1/20 0.30
AURKB Q96GD4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25535205 0.95 MAPT (0.32) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL25534915 0.94 TDP1 (0.32) ALDH1A1MAPTHPGDALOX5MEN1
SCHEMBL23963480 0.94 MEN1 (0.36) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL25534675 0.93 MEN1 (0.33) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20647407 0.92 MAPT (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL20647396 0.92 MAPT (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL25534929 0.89 MEN1 (0.38) ALDH1A1MAPTHPGDSMN1; SMN2MEN1
SCHEMBL25535211 0.89 PIM3 (0.32) ALDH1A1MAPTHPGDSMN1; SMN2MEN1
SCHEMBL25535009 0.89 MAPT (0.34) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL25535523 0.89 KDM4E (0.31) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885MAPT 1595/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.